REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/14/2026
Back to search
Official data from USPTO
DIPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
08/14/2026
Trademark type
Combined
Nice classes
1
Filing date
09/27/2005
Registration date
08/14/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2017
Last transaction
08/14/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
10
Owner location
I-20021 Baranzate (MI), IT
Examiner
COLEMAN, CIMMERIAN
Law office
L20
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a Complex trademark consisting of the word "Dipharma" in special fonts, the first letter being capital. At the left side of the trademark there appears an equilateral triangle, the left side of which is perpendicular to the base of the trademark and the sides of which are the main bases of three identical trapeziums.
Holders and representatives
Holders
Dipharma Francis S.r.l.
Dipharma Francis S.r.l.
Dipharma S.p.A.
Representatives
Stewart J. Bellus Collard & Roe, P.C.
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in the manufacture of active pharmaceutical ingredients; chemical compositions being active ingredients for use in the manufacture of various pharmaceutical preparationsnamely antimycotic/antifungal preparationsantiallergic preparationsantihistaminic preparationsantiasthmatic preparationsantiacne preparationsantimigraine preparationsantimalarial/antiprotozoal preparationsantithrombotic preparationsnootropic preparationsantiglaucoma preparationsimmunomodulator preparationsCNS stimulant preparationsantibacterial/antibiotic preparationsantiulcerative/gastric proton pump inhibitor preparationsACE inhibitor preparationsantihypertensive preparationsantiParkinson/Dopamine receptor agonist preparationsantimuscarinic (anti urinary incontinence) preparationsantidepressant/serotonin noradrenaline reuptake inhibitor preparationsanalgesic preparationsantipsychotic preparationsdopamine receptor antagonist preparationssedative/hypnotic preparations and anticonvulsant preparations
Publications
History of USPTO decisions and trademark events.
43 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
07/03/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/27/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/01/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/27/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/17/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/16/2017
71AG
REGISTERED-SEC.71 ACCEPTED
05/16/2017
ES71
TEAS SECTION 71 RECEIVED
05/15/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/15/2015
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
11/17/2012
NA15
SEC. 15 ACKNOWLEDGEMENT - MAILED
11/17/2012
71AG
REGISTERED-SEC.71 ACCEPTED
11/17/2012
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
11/17/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/21/2012
E15R
TEAS SECTION 15 RECEIVED
10/18/2012
ES71
TEAS SECTION 71 RECEIVED
10/17/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/08/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/08/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2008
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
12/20/2007
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/06/2007
FIMP
FINAL DISPOSITION PROCESSED
12/06/2007
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/19/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
08/14/2007
ISIR
WITHDRAWN FROM ISSUE - TQR/NON-ATTY REQUEST
07/11/2007
OP.T
OPPOSITION TERMINATED NO. 999999
06/20/2007
OP.D
OPPOSITION DISMISSED NO. 999999
06/20/2007
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/10/2007
RFNP
REFUSAL PROCESSED BY IB
09/15/2006
OP.I
OPPOSITION INSTITUTED NO. 999999
09/01/2006
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
08/31/2006
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
08/31/2006
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/11/2006
PUBO
PUBLISHED FOR OPPOSITION
06/13/2006
NPUB
NOTICE OF PUBLICATION
05/24/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/20/2006
ALIE
ASSIGNED TO LIE
04/14/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/12/2006
DOCK
ASSIGNED TO EXAMINER
03/30/2006
NWAP
NEW APPLICATION ENTERED
11/18/2005
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/17/2005
Continuous trademark protection
Get notified about every new filing that threatens DIPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.